Refine Search
(6)
(8)
(8)
(8)

Digestive Disorders & Gastrointestinal Diseases

For the past few years, the market for drugs that treat gastrointestinal diseases has been highly genericized. However, the effort to develop novel drugs gained momentum in the recent past, with particular attention to biologics, especially the monoclonal antibodies. The gastrointestinal therapy area has the seventh-largest pipeline among entire disease categories, having more active pipeline drugs than therapy areas such as respiratory and ophthalmology.

Irritable Bowel Syndrome - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H1 2018’, provides an overview of the Irritable Bowel Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Gastritis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastritis - Pipeline Review, H1 2018’, provides an overview of the Gastritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastritis, complete with a...

Ulcerative Colitis - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2018’, provides an overview of the Ulcerative Colitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ulcerati...

Celiac Disease - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Celiac Disease - Pipeline Review, H1 2018’, provides an overview of the Celiac Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Celiac Disease, ...

Pancreatitis - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pancreatitis - Pipeline Review, H1 2018’, provides an overview of the Pancreatitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pancreatitis, comple...

Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

The report provides comprehensive information on the...

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2018

  • $2,000
  • January 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2018, provides an overview of the Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipelin...

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2018

  • $2,000
  • January 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2018, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestina...